Report overview
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery Systems. This report contains market size and forecasts of Transdermal Drug Delivery Systems in global, including the following market information:
Global Transdermal Drug Delivery Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Transdermal Drug Delivery Systems market was valued at US$ 15500 million in 2022 and is projected to reach US$ 19260 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
We surveyed the Transdermal Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Drug Delivery Systems Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Transdermal Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Global Transdermal Drug Delivery Systems Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Transdermal Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)
OTC
Rx
Global Transdermal Drug Delivery Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Transdermal Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Drug Delivery Systems revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Transdermal Drug Delivery Systems revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Novartis
Teve (Actavis)
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal Drug Delivery Systems, market overview.
Chapter 2: Global Transdermal Drug Delivery Systems market size in revenue.
Chapter 3: Detailed analysis of Transdermal Drug Delivery Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
